Literature DB >> 7138742

Pyridostigmine in human breast milk.

L I Hardell, B Lindström, G Lönnerholm, P O Osterman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138742      PMCID: PMC1427605     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Clinical pharmacokinetics in infants and children.

Authors:  A Rane; J T Wilson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  The role of anti-acetylcholine receptor antibody in neonatal myasthenia gravis.

Authors:  R R Skoglund; C C Roberts; J Huddlestone
Journal:  Bull Los Angeles Neurol Soc       Date:  1978

3.  A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma.

Authors:  K Chan; N E Williams; J D Baty; T N Calvey
Journal:  J Chromatogr       Date:  1976-05-26

4.  Pharmacokinetics and oral bioavailability of pyridostigmine in man.

Authors:  S M Aquilonius; S A Eckernäs; P Hartvig; B Lindström; P O Osterman
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

5.  Renal clearance of pyridostigmine in patients with myasthenia gravis.

Authors:  K Chan; T N Calvey
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

  5 in total
  5 in total

Review 1.  [Anesthesia in the breast feeding period. Excretion of anesthetic agents and adjuvants into breast milk and potential pharmacological side-effects on the suckling infant].

Authors:  C Lang; G Geldner; H Wulf
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

2.  Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.

Authors:  K Yamamoto; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

Review 3.  Clinical pharmacokinetics of cholinesterase inhibitors.

Authors:  S M Aquilonius; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 4.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.